Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 23, 2016
Apotex has launched the first generic version of Merck's Nasonex® nasal spray (mometasone furoate monohydrate) in the United States.
read more
Friday, December 18, 2020
Apotex has announced its board of directors has appointed Peter Hardwick as President & Chief Executive Officer of Apotex Corp., effective immediately.
read more
Apotex has received a Drug Shortage Assistance Award from the FDA in recognition of the company's substantial efforts to resolve a shortage of varenicline tablets.
read more
Applied BioMath has announced a collaboration with Northern Biologics focused on traditional and mechanistic pharmacokinetic and pharmacodynamics (PK/PD) modeling for a biotherapeutic candidate in oncology.
read more
Wednesday, August 07, 2019
Applied DNA Sciences has announced the signing of a Master Services Agreement with Germany-based Schreiner Group through its Schreiner MediPharm business unit.
read more
Monday, February 03, 2020
Applied Photophysics has its Board of Directors has appointed Tim Flanagan as Chief Executive Officer and member of the Board of Directors effective immediately.
read more
Applied Photophysics and Fluorescence Innovations have entered into a joint venture agreement to develop and produce protein stability systems for researchers and industries globally.
read more
Applied StemCell has joined the National Institute of Standards and Technology (NIST) Genome Editing Consortium.
read more
Monday, November 06, 2017
Applied StemCell has received certifications for two ISO QMS on October 20, 2017, the ISO 9001:2015 and 13485:2016.
read more
Tuesday, December 22, 2020
Aprecia is partnering with Battelle to accelerate and expand its advanced capabilities in 3DP pharmaceutical manufacturing.
read more
Aprecia and CMIC CMO announced both companies will collaborate to develop business opportunities in Japan for Aprecia's ZipDose® Technology.
read more
Friday, February 21, 2020
Purdue University's College of Pharmacy and Aprecia Pharmaceuticals are launching a comprehensive collaboration on future 3DP pharmaceutical equipment and medications.
read more
Aptamer Group Ltd, the developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB, the developer and manufacturer of leading-edge agarose-based purification ...
read more
Aptamer Group, the developer of diagnostic and therapeutic Optimer™ reagents, announced that it has signed an agreement with the multinational pharmaceutical and biopharmaceutical company Takeda Pharmaceutical Company Limited (“Takeda”).
read more
Wednesday, September 03, 2025
Aptamer Group ,a developer of synthetic binders for the life science industry, announced the launch of its biomarker discovery service, offering researchers in pharmaceutical, biotechnology, and diagnostic development an innovative approach to ...
read more